z-logo
open-access-imgOpen Access
Correction to: Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study, by Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y, Eberly LE, Carstedt P, Samikoglu A, Gunlicks-Stoessel M, Reigstad K, Horek N, Tye S, Lim KO, Klimes-Dougan B. J Child Adolesc Psychopharmacol 2018;28(7):437–444. DOI: 10.1089/cap.2018.0030
Author(s) -
Kathyrn Cullen,
Palistha Amatya,
Mark G. Roback,
C. Sophia Albott,
Melinda Westlund Schreiner,
Yanan Ren,
Lynn E. Eberly,
Patricia Carstedt,
Ali Samikoglu,
Meredith GunlicksStoessel,
Kristina Reigstad,
Nathan Horek,
Susannah J. Tye,
Kelvin O. Lim,
Bonnie KlimesDougan
Publication year - 2018
Publication title -
journal of child and adolescent psychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.935
H-Index - 84
eISSN - 1557-8992
pISSN - 1044-5463
DOI - 10.1089/cap.2018.0030.correx
Subject(s) - treatment resistant depression , ketamine , depression (economics) , psychiatry , psychology , library science , medicine , major depressive disorder , cognition , computer science , economics , macroeconomics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom